Hostname: page-component-669899f699-2mbcq Total loading time: 0 Render date: 2025-04-25T17:25:27.630Z Has data issue: false hasContentIssue false
  • English
  • Français

Importance of Pharmacy Partnerships in Effective COVID-19 Vaccine Distribution

Published online by Cambridge University Press:  08 June 2021

Rajkumar S. Pammal Open the ORCID record for Rajkumar S. Pammal [Opens in a new window] ,
Jason B. Kreinces  and
Kevin L. Pohlman
Rajkumar S. Pammal*
Affiliation:
New York Medical College School of Medicine, Valhalla, New York, USA
Jason B. Kreinces
Affiliation:
New York Medical College School of Medicine, Valhalla, New York, USA
Kevin L. Pohlman
Affiliation:
New York Medical College School of Health Sciences and Practice, Center for Disaster Medicine, Valhalla, New York, USA
*
Corresponding author: Rajkumar S. Pammal, Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

The goal of vaccinating the majority of Americans against coronavirus disease 2019 (COVID-19) in a timely manner requires a robust federal vaccine distribution plan involving pharmacy partnerships. Previously, the 2009 Centers for Disease Control and Prevention (CDC) H1N1 Vaccine Pharmacy Initiative resulted in approximately 10% of adults who received a vaccine during the 2009 pandemic reporting they were vaccinated at a pharmacy. This proportion has already largely increased for COVID-19 vaccinations, with the US Department of Health and Human Services (HHS) using similar channels for vaccination as existing partnerships with national pharmacy and grocery retail chains for the COVID-19 Community-Based Testing Program. It continues to prove crucial that the Biden administration’s national COVID-19 vaccine distribution plan, including the Federal Retail Pharmacy Program, focus on ensuring equitable vaccine distribution and access in medically underserved areas and to vulnerable populations, enabling maximum uptake of COVID-19 vaccines.

Keywords

COVID-19vaccinationpharmacy partnershipshealth equity
Type
Policy Analysis
Information
Disaster Medicine and Public Health Preparedness , Volume 16 , Issue 6 , December 2022 , pp. 2293 - 2295
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Superville, D, Jaffe, A. Biden makes all adults eligible for a vaccine on April 19. AP News. April 6, 2021, https://apnews.com/article/biden-move-vaccine-eligibility-date-april-19-021157c7bdf964181e3b63f51b89601e. Accessed June 17, 2021.Google Scholar
The White House. FACT SHEET: President Biden announces 90% of the adult US population will be eligible for vaccination and 90% will have a vaccination site within 5 miles of home by April 19.” The United States Government. March 29, 2021. www.whitehouse.gov/briefing-room/statements-releases/2021/03/29/fact-sheet-president-biden-announces-90-of-the-adult-u-s-population-will-be-eligible-for-vaccination-and-90-will-have-a-vaccination-site-within-5-miles-of-home-by-april-19/. Accessed June 17, 2021.Google Scholar
Escuyer, KL, Fuschino, ME, St George, K. New York State emergency preparedness and response to influenza pandemics 1918-2018. Trop Med Infect Dis. 2019;4(4):132. doi: 10.3390/tropicalmed4040132 CrossRefGoogle ScholarPubMed
Dimitrov, NB, Goll, S, Hupert, N, et al. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza. PLoS One. 2011;6(1):e16094.CrossRefGoogle ScholarPubMed
Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic Events. The 2009 H1N1 influenza vaccination campaign: summary of a workshop series. Washington, DC: National Academies Press; 2010. 3, Vaccine Distribution. https://www.ncbi.nlm.nih.gov/books/NBK54182/. Accessed June 17, 2021.Google Scholar
Koonin, LM, Beauvais, DR, Shimabukuro, T, et al. CDC’s 2009 H1N1 vaccine pharmacy initiative in the United States: implications for future public health and pharmacy collaborations for emergency response. Disaster Med Public Health Prep. 2011;5(4):253-255. doi: 10.1001/dmp.2011.83 Google ScholarPubMed
Centers for Disease Control and Prevention. COVID-19 Vaccination Federal Retail Pharmacy Partnership Program. Centers for Disease Control and Prevention. April 12, 2021. www.cdc.gov/vaccines/covid-19/retail-pharmacy-program/index.html. Accessed June 17, 2021.Google Scholar
Strand, MA, Bratberg, J, Eukel, H, et al. Community pharmacists’ contributions to disease management during the COVID-19 pandemic. Prev Chronic Dis. 2020;17:E69. doi: 10.5888/pcd17.200317 CrossRefGoogle ScholarPubMed
Czech, M, Balcerzak, M, Antczak, A, et al. Flu vaccinations in pharmacies-a review of pharmacists fighting pandemics and infectious diseases. Int J Environ Res Public Health. 2020;17(21):7945. doi: 10.3390/ijerph17217945 CrossRefGoogle ScholarPubMed
HHS.gov. Trump administration partners with chain and independent community pharmacies to increase access to future COVID-19 vaccines. December 31, 2020, www.hhs.gov/about/news/2020/11/12/trump-administration-partners-chain-independent-community-pharmacies-increase-access-future-covid-19-vaccines.html. Accessed June 17, 2021.Google Scholar
Fein, AJ. The 2021 economic report on US pharmacies and pharmacy benefit managers. Drug Channels Institute. 2020. https://drugchannelsinstitute.com/products/industry_report/pharmacy/. Accessed June 17, 2021.Google Scholar
Rapfogel, N. How Biden’s coronavirus plan funds and supports state vaccination efforts. Center for American Progress. February 11, 2021. www.americanprogress.org/issues/healthcare/news/2021/02/11/495712/bidens-coronavirus-plan-funds-supports-state-vaccination-efforts/. Accessed June 17, 2021.Google Scholar
Painter, EM, Ussery, EN, Patel, A, et al. Demographic characteristics of persons vaccinated during the first month of the COVID-19 vaccination program - United States, December 14, 2020-January 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(5):174-177. doi: 10.15585/mmwr.mm7005e1 CrossRefGoogle ScholarPubMed
The White House. FACT SHEET: Biden administration announces historic $10 billion investment to expand access to COVID-19 vaccines and build vaccine confidence in hardest-hit and highest-risk communities. The United States Government. March 25, 2021. https://www.whitehouse.gov/briefing-room/statements-releases/2021/03/25/fact-sheet-biden-administration-announces-historic-10-billion-investment-to-expand-access-to-covid-19-vaccines-and-build-vaccine-confidence-in-hardest-hit-and-highest-risk-communities/. Accessed June 17, 2021.Google Scholar
Blumenthal, D, McClellan, M, Tewarson, H, et al. States need federal help to get COVID-19 vaccines into millions of arms.” Commonwealth Fund. December 2020. www.commonwealthfund.org/blog/2020/states-need-federal-help-get-covid-19-vaccines-millions-arms. Accessed June 17, 2021.Google Scholar
Michaud, J, Kates, J, Dolan, R, et al. States are getting ready to distribute COVID-19 vaccines. What do their plans tell us so far? KFF. January 7, 2021. www.kff.org/coronavirus-covid-19/issue-brief/states-are-getting-ready-to-distribute-covid-19-vaccines-what-do-their-plans-tell-us-so-far/. Accessed June 17, 2021.Google Scholar
HHS.gov. HHS to expand access to COVID-19 vaccines for older adults and people with disabilities. March 29. 2021. www.hhs.gov/about/news/2021/03/29/hhs-to-expand-access-to-covid-19-vaccines-for-older-adults-and-people-with-disabilities.html. Accessed June 17, 2021.Google Scholar
CDC. Understanding the pharmacy partnership for long-term care program. CDC.gov. December 9, 2020. https://www.cdc.gov/vaccines/covid-19/long-term-care/pharmacy-partnerships.html. Accessed June 17, 2021.Google Scholar
Weintraub, RL, Subramanian, L, Karlage, A, et al. COVID-19 vaccine to vaccination: why leaders must invest in delivery strategies now. Health Aff (Millwood). 2021;40(1):33-41. doi: 10.1377/hlthaff.2020.01523 Google ScholarPubMed